Generalized epilepsy with febrile seizures plus

File:Sodium channel beta GEFS plus.png

File:GABRG2 GEFS plus.png

File:SCN2A GEFS plus.png

Generalized Epilepsy with Febrile Seizures Plus

Generalized Epilepsy with Febrile Seizures Plus (GEFS+) is a familial epilepsy syndrome characterized by a spectrum of seizure types, including febrile seizures and afebrile generalized seizures. It is a genetically heterogeneous condition, meaning it can be caused by mutations in different genes.

Clinical Features

GEFS+ is defined by the presence of febrile seizures that persist beyond the typical age range (6 months to 5 years) and the occurrence of other types of seizures, such as generalized tonic-clonic seizures, myoclonic seizures, or absence seizures. The clinical presentation can vary significantly among affected individuals, even within the same family.

Febrile Seizures

Febrile seizures are convulsions triggered by fever in young children. In GEFS+, these seizures may continue beyond the usual age limit and can be more frequent or severe.

Afebrile Seizures

Individuals with GEFS+ may experience afebrile seizures, which are not associated with fever. These can include:

• Generalized tonic-clonic seizures: Characterized by loss of consciousness and convulsions.
• Myoclonic seizures: Brief, shock-like jerks of a muscle or group of muscles.
• Absence seizures: Brief episodes of staring and unresponsiveness.

Genetic Basis

GEFS+ is associated with mutations in several genes, most notably:

• SCN1A: This gene encodes a subunit of the sodium channel, which is crucial for the generation and propagation of action potentials in neurons.
• SCN1B: Another gene encoding a sodium channel subunit.
• GABRG2: This gene encodes a subunit of the GABA_A receptor, which is involved in inhibitory neurotransmission.

The inheritance pattern of GEFS+ is typically autosomal dominant, meaning a single copy of the mutated gene can cause the disorder.

Diagnosis

Diagnosis of GEFS+ is based on clinical evaluation, family history, and genetic testing. EEG (electroencephalogram) may show generalized epileptiform activity, but findings can be variable.

Management

Management of GEFS+ involves the use of antiepileptic drugs (AEDs) to control seizures. The choice of medication depends on the specific seizure types present in the individual. Commonly used AEDs include valproate, lamotrigine, and topiramate.

Prognosis

The prognosis for individuals with GEFS+ varies. Some individuals may experience a reduction in seizure frequency with age, while others may continue to have seizures into adulthood. The response to treatment can also vary.

Also see

• Febrile seizures
• Generalized tonic-clonic seizure
• Myoclonic seizure
• Absence seizure
• SCN1A
• GABRG2